We are live on ! Find out more
SYRE icon

Spyre Therapeutics

197 hedge funds and large institutions have $4.16B invested in Spyre Therapeutics in 2026 Q1 according to their latest regulatory filings, with 58 funds opening new positions, 66 increasing their positions, 49 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

952% more call options, than puts

Call options by funds: $16.4M | Put options by funds: $1.55M

427% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 11

67% more funds holding in top 10

Funds holding in top 10: 610 (+4)

57% more capital invested

Capital invested by funds: $2.65B → $4.16B (+$1.51B)

35% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 49

29% more funds holding

Funds holding: 153197 (+44)

0.87% more ownership

Funds ownership: 104.36%105.23% (+0.87%)

Holders
197
Holders Change
+44
Holders Change %
+28.76%
% of All Funds
2.43%
Holding in Top 10
10
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+66.67%
% of All Funds
0.12%
New
58
Increased
66
Reduced
49
Closed
11
Calls
$16.4M
Puts
$1.55M
Net Calls
+$14.8M
Net Calls Change
+$2.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CC
201
Caxton Corporation
New Jersey
-$292K -8,919 Closed
VC
202
VarCov Co
Connecticut
-$262K -8,008 Closed
BHCM
203
Brevan Howard Capital Management
Jersey
-$203K -6,198 Closed
A
204
AlphaQuest
New York
-$116K -3,538 Closed
AB
205
Amalgamated Bank
New York
-$71K -2,165 Closed
Daiwa Securities Group
206
Daiwa Securities Group
Japan
-$8K -258 Closed
MAM
207
Meeder Asset Management
Ohio
-$5.93K -181 Closed
C
208
Covestor
United Kingdom
-$75 -2 -33%